ATE131055T1 - Behandlung von kognitiven störungen. - Google Patents
Behandlung von kognitiven störungen.Info
- Publication number
- ATE131055T1 ATE131055T1 AT92906578T AT92906578T ATE131055T1 AT E131055 T1 ATE131055 T1 AT E131055T1 AT 92906578 T AT92906578 T AT 92906578T AT 92906578 T AT92906578 T AT 92906578T AT E131055 T1 ATE131055 T1 AT E131055T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- cognitive disorders
- patient
- compound
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Processing Of Meat And Fish (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK036291A DK36291D0 (da) | 1991-03-01 | 1991-03-01 | Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE131055T1 true ATE131055T1 (de) | 1995-12-15 |
Family
ID=8092662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92906578T ATE131055T1 (de) | 1991-03-01 | 1992-02-28 | Behandlung von kognitiven störungen. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5444073A (de) |
| EP (1) | EP0575429B1 (de) |
| JP (1) | JP3108434B2 (de) |
| KR (1) | KR0183424B1 (de) |
| AT (1) | ATE131055T1 (de) |
| AU (1) | AU663699B2 (de) |
| CA (1) | CA2105385C (de) |
| CY (1) | CY2083B1 (de) |
| DE (1) | DE69206607T2 (de) |
| DK (2) | DK36291D0 (de) |
| HK (1) | HK1003560A1 (de) |
| IE (1) | IE70600B1 (de) |
| IL (1) | IL101102A (de) |
| NO (1) | NO307406B1 (de) |
| NZ (1) | NZ241800A (de) |
| WO (1) | WO1992015303A1 (de) |
| ZA (1) | ZA921462B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5468768A (en) * | 1994-01-06 | 1995-11-21 | Bristol-Myers Squibb Company | Antimigraine derivatives of indolylcycloalkanylamines |
| US6489341B1 (en) | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
| ES2326078T3 (es) | 2002-08-22 | 2009-09-30 | Dainippon Sumitomo Pharma Co., Ltd. | Medicamento destinado al sindrome de la disfuncion de integracion. |
| CN1826338B (zh) | 2003-06-23 | 2011-07-13 | 大日本住友制药株式会社 | 老年性痴呆症治疗药 |
| US20070160537A1 (en) | 2004-02-20 | 2007-07-12 | Takeo Ishiyama | In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| US20070212412A1 (en) * | 2005-09-08 | 2007-09-13 | H. Lundbeck A/S | Stable solid formulation of sertindole |
| TW200821296A (en) * | 2006-06-01 | 2008-05-16 | Lundbeck & Co As H | Use of sertindole for the preventive treatment of suicidal behaviour |
| US8258139B2 (en) | 2010-11-08 | 2012-09-04 | Dainippon Sumitomo Pharma Co., Ltd. | Method of treatment for mental disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL48508A (en) * | 1974-12-09 | 1979-10-31 | Roussel Uclaf | Pharmaceutical compositions comprising piperidylindole derivatives |
| FR2362628A1 (fr) * | 1976-08-26 | 1978-03-24 | Roussel Uclaf | Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments |
| SE8004129L (sv) * | 1979-07-13 | 1981-01-14 | Roussel Uclaf | Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar |
| IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
| GB8704572D0 (en) * | 1987-02-26 | 1987-04-01 | Lundbeck & Co As H | Organic compounds |
| DK158590D0 (da) * | 1990-07-02 | 1990-07-02 | Lundbeck & Co As H | Indolderivater |
-
1991
- 1991-03-01 DK DK036291A patent/DK36291D0/da not_active Application Discontinuation
-
1992
- 1992-02-24 IE IE920572A patent/IE70600B1/en not_active IP Right Cessation
- 1992-02-27 ZA ZA921462A patent/ZA921462B/xx unknown
- 1992-02-28 DK DK92906578.7T patent/DK0575429T3/da active
- 1992-02-28 AU AU13707/92A patent/AU663699B2/en not_active Ceased
- 1992-02-28 CA CA002105385A patent/CA2105385C/en not_active Expired - Fee Related
- 1992-02-28 JP JP04505932A patent/JP3108434B2/ja not_active Expired - Fee Related
- 1992-02-28 IL IL10110292A patent/IL101102A/en not_active IP Right Cessation
- 1992-02-28 WO PCT/DK1992/000063 patent/WO1992015303A1/en active IP Right Grant
- 1992-02-28 KR KR1019930702618A patent/KR0183424B1/ko not_active IP Right Cessation
- 1992-02-28 AT AT92906578T patent/ATE131055T1/de not_active IP Right Cessation
- 1992-02-28 EP EP92906578A patent/EP0575429B1/de not_active Expired - Lifetime
- 1992-02-28 DE DE69206607T patent/DE69206607T2/de not_active Expired - Fee Related
- 1992-03-02 NZ NZ241800A patent/NZ241800A/en not_active IP Right Cessation
-
1993
- 1993-08-31 NO NO933091A patent/NO307406B1/no not_active IP Right Cessation
- 1993-09-01 US US08/115,449 patent/US5444073A/en not_active Expired - Lifetime
-
1998
- 1998-03-20 HK HK98102377A patent/HK1003560A1/xx not_active IP Right Cessation
- 1998-10-16 CY CY9802083A patent/CY2083B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU663699B2 (en) | 1995-10-19 |
| EP0575429B1 (de) | 1995-12-06 |
| NO307406B1 (no) | 2000-04-03 |
| DK0575429T3 (da) | 1996-04-22 |
| KR0183424B1 (ko) | 1999-05-01 |
| CY2083B1 (en) | 1998-10-16 |
| IL101102A (en) | 1996-03-31 |
| US5444073A (en) | 1995-08-22 |
| HK1003560A1 (en) | 1998-10-30 |
| CA2105385A1 (en) | 1992-09-02 |
| NO933091D0 (no) | 1993-08-31 |
| NZ241800A (en) | 1997-03-24 |
| DK36291D0 (da) | 1991-03-01 |
| EP0575429A1 (de) | 1993-12-29 |
| ZA921462B (en) | 1992-11-25 |
| IE70600B1 (en) | 1996-12-11 |
| KR930702978A (ko) | 1993-11-29 |
| WO1992015303A1 (en) | 1992-09-17 |
| NO933091L (no) | 1993-11-01 |
| DE69206607T2 (de) | 1996-05-15 |
| DE69206607D1 (de) | 1996-01-18 |
| JPH06504787A (ja) | 1994-06-02 |
| JP3108434B2 (ja) | 2000-11-13 |
| IL101102A0 (en) | 1992-11-15 |
| CA2105385C (en) | 2000-08-15 |
| AU1370792A (en) | 1992-10-06 |
| IE920572A1 (en) | 1992-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO974163D0 (no) | Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi | |
| MY117896A (en) | Quinazoline derivatives | |
| NO944018D0 (no) | Behandling av makulær degenerasjon | |
| FI102964B1 (fi) | Terapeuttisia yhdisteitä | |
| ATE131055T1 (de) | Behandlung von kognitiven störungen. | |
| ES539123A0 (es) | Un compuesto de 3-indolcarboxamida | |
| ES2053668T3 (es) | Derivados de poliamina como agentes antineoplasicos. | |
| ZA922910B (en) | Heterocylic pharmaceutical compounds preparation and use | |
| ES8103071A1 (es) | Procedimiento de preparacion de nuevos derivados aminicos del benzotiazol | |
| DE69030665D1 (de) | (1,2n) und (3,2n)-karbozyklische-2-amino-tetralinderivate | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| DE69419954D1 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
| MY133438A (en) | Morpholinobenzamide salts | |
| DE69906728D1 (de) | Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen | |
| DE69117923D1 (de) | Pharmazeutische zusammensetzungen zur aids-behandlung | |
| ATE147978T1 (de) | Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| ATE254919T1 (de) | Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8 | |
| DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |